|
[1]
|
Bovet, P. and Chiolero, A. (2018) Prevalence and Control of Hypertension. Lancet, 392, 1305-1306. [Google Scholar] [CrossRef]
|
|
[2]
|
The Writing Committee of the Report on Cardiovascular H, Diseases in C. (2021) Report on Cardiovascular Health and Diseases in China 2020. Chinese Journal of Cardiovascular Research, 19, 582-590.
|
|
[3]
|
冯彦成, 冯淼, 马永红, 等. 我国南北方成年居民高血压患病影响因素差异性分析及公共卫生防控策略研究[J]. 中国卫生统计, 2023, 40(6): 860-864.
|
|
[4]
|
Lewington, S., Lacey, B., Clarke, R., et al. (2016) The Burden of Hypertension and Associated Risk for Cardiovascular Mortality in China. JAMA Internal Medicine, 176, 524-532. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
王黎. 昼夜节律紊乱、RBP4在轮班增加2型糖尿病患病风险中的作用[D]: [博士学位论文]. 乌鲁木齐: 新疆医科大学, 2023.[CrossRef]
|
|
[6]
|
葛均波, 徐永健, 梅长林, 等. 内科学[M]. 第8版. 北京: 人民卫 生出版社, 2013: 257-262.
|
|
[7]
|
Von Eynatten, M. and Humpert, P.M. (2008) Retinol-Binding Protein-4 in Experimental and Clinical Metabolic Disease. Expert Review of Molecular Diagnostics, 8, 289-299. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Yang, Q., Graham, T.E., Mody, N, et al. (2005) Serum Retinol Binding Protein 4 Contributes to Insulin Resistance in Obesity and Type 2 Diabetes. Nature, 436, 356-362. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Graham, T.E., Yang, Q., Blüher, M., et al. (2006) Retinol-Binding Protein 4 and Insulin Resistance in Lean, Obese, and Diabetic Subjects. The New England Journal of Medicine, 354, 2552-2563. [Google Scholar] [CrossRef]
|
|
[10]
|
Janke, J., Engeli, S., Boschmann, M., et al. (2006) Retinol-Binding Protein 4 in Human Obesity. Diabetes, 55, 2805-2810. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Olsen, T. and Blomhoff, R. (2020) Retinol, Retinoic Acid, and Retinol-Binding Protein 4 Are Differentially Associated with Cardiovascular Disease, Type 2 Diabetes, and Obesity: An Overview of Human Studies. Advances in Nutrition, 11, 644-666. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Liu, J. (2020) Highlights of the 2018 Chinese Hypertension Guidelines. Clinical Hypertension, 26, 8. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Revision Jcfg. (2018) 2016 Chinese Guidelines for the Management of Dyslipidemia in Adults. Journal of Geriatric Cardiology, 15, 1-29.
|
|
[14]
|
李秀珍. RBP4与原发性高血压的相关性及机制研究[D]: [博士学位论文]. 南京: 南京医科大学, 2019.[CrossRef]
|
|
[15]
|
李友盼. 血清CysC与原发性高血压患者左心室肥厚的相关性研究[D]: [博士学位论文]. 昆明: 昆明医科大学, 2020.[CrossRef]
|
|
[16]
|
Schiborn, C., Weber, D., Grune, T., Biemann, R., Jäger, S., Neu, N., Müller Von Blumencron, M., Fritsche, A., Weikert, C., Schulze, M.B. and Wittenbecher, C. (2022) Retinol and Retinol Binding Protein 4 Levels and Cardiometabolic Disease Risk. Circulation Research, 131, 637-649. [Google Scholar] [CrossRef]
|
|
[17]
|
张康伟, 曹友红, 刘秀玲. 老年性高血压的治疗与心脑血管疾病处理探讨[J]. 中西医结合心血管病电子杂志, 2021, 9(32): 71-73. [Google Scholar] [CrossRef]
|
|
[18]
|
杨靓宇, 田颖, 陈磊. 高血压患者血压变异性与左室射血分数及超敏C反应蛋白的关系[J]. 继续医学教育, 2016, 30(4): 115-116.
|
|
[19]
|
梁丽冰, 陈静娟, 章成国, 王玉凯, 罗柏桂, 周天恩, 王晓锋. 血清脂蛋白相关磷脂酶A2水平与伴高血压的急性缺血性脑梗死复发正相关[J]. 南方医科大学学报, 2023, 43(2): 317-322.
|